Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [[maximum depth reached]]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-trace').style.display = (document.getElementById('cakeErr67ed615148a59-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ed615148a59-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-code').style.display = (document.getElementById('cakeErr67ed615148a59-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-context').style.display = (document.getElementById('cakeErr67ed615148a59-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ed615148a59-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ed615148a59-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 63323,
		&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 63323,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 63323,
	&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 63323
$metaTitle = &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;
$metaKeywords = &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;
$metaDesc = &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill | Im4change.org</title>
    <meta name="description" content="-The Telegraph

There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Expired pill: Editorial on new drugs and cosmetics bill</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p><p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503" title="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-trace').style.display = (document.getElementById('cakeErr67ed615148a59-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ed615148a59-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-code').style.display = (document.getElementById('cakeErr67ed615148a59-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-context').style.display = (document.getElementById('cakeErr67ed615148a59-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ed615148a59-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ed615148a59-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 63323,
		&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 63323,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 63323,
	&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 63323
$metaTitle = &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;
$metaKeywords = &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;
$metaDesc = &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill | Im4change.org</title>
    <meta name="description" content="-The Telegraph

There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Expired pill: Editorial on new drugs and cosmetics bill</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p><p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503" title="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-trace').style.display = (document.getElementById('cakeErr67ed615148a59-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67ed615148a59-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-code').style.display = (document.getElementById('cakeErr67ed615148a59-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67ed615148a59-context').style.display = (document.getElementById('cakeErr67ed615148a59-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67ed615148a59-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67ed615148a59-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 63323,
		&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
		&#039;subheading&#039; =&gt; null,
		&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
		&#039;meta_title&#039; =&gt; &#039;&#039;,
		&#039;meta_keywords&#039; =&gt; &#039;&#039;,
		&#039;meta_description&#039; =&gt; &#039;&#039;,
		&#039;noindex&#039; =&gt; (int) 1,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; null,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 63323,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 63323,
	&#039;title&#039; =&gt; &#039;Expired pill: Editorial on new drugs and cosmetics bill&#039;,
	&#039;subheading&#039; =&gt; null,
	&#039;description&#039; =&gt; &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;

&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;
&amp;nbsp;&lt;/p&gt;
&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;expired-pill-editorial-on-new-drugs-and-cosmetics-bill&#039;,
	&#039;meta_title&#039; =&gt; &#039;&#039;,
	&#039;meta_keywords&#039; =&gt; &#039;&#039;,
	&#039;meta_description&#039; =&gt; &#039;&#039;,
	&#039;noindex&#039; =&gt; (int) 1,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; null,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {},
		(int) 7 =&gt; object(Cake\ORM\Entity) {},
		(int) 8 =&gt; object(Cake\ORM\Entity) {},
		(int) 9 =&gt; object(Cake\ORM\Entity) {},
		(int) 10 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 63323
$metaTitle = &#039;LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill&#039;
$metaKeywords = &#039;good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines&#039;
$metaDesc = &#039;-The Telegraph

There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...&#039;
$disp = &#039;&lt;p style=&quot;text-align:justify&quot;&gt;-The Telegraph&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;&lt;em&gt;There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors&lt;/em&gt;&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &amp;lsquo;good manufacturing practices&amp;rsquo; &amp;mdash; a global standard when it comes to testing drugs &amp;mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &amp;mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &amp;mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &amp;lsquo;open source vaccines&amp;rsquo; &amp;mdash; generic versions of the vaccines already being used successfully &amp;mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.&lt;/p&gt;&lt;p style=&quot;text-align:justify&quot;&gt;Please &lt;a href=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot; title=&quot;https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503&quot;&gt;click here&lt;/a&gt; to read more.&amp;nbsp;&lt;br /&gt;&amp;nbsp;&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/expired-pill-editorial-on-new-drugs-and-cosmetics-bill.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill | Im4change.org</title>
    <meta name="description" content="-The Telegraph

There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Expired pill: Editorial on new drugs and cosmetics bill</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p><p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503" title="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />&nbsp;</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 63323,
		'title' => 'Expired pill: Editorial on new drugs and cosmetics bill',
		'subheading' => null,
		'description' => '<p style="text-align:justify">-The Telegraph</p>

<p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p>

<p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p>

<p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />
&nbsp;</p>
',
		'credit_writer' => 'The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'expired-pill-editorial-on-new-drugs-and-cosmetics-bill',
		'meta_title' => '',
		'meta_keywords' => '',
		'meta_description' => '',
		'noindex' => (int) 1,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => null,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 63323,
	'metaTitle' => 'LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill',
	'metaKeywords' => 'good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines',
	'metaDesc' => '-The Telegraph

There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...',
	'disp' => '<p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p><p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503" title="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />&nbsp;</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 63323,
	'title' => 'Expired pill: Editorial on new drugs and cosmetics bill',
	'subheading' => null,
	'description' => '<p style="text-align:justify">-The Telegraph</p>

<p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p>

<p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p>

<p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />
&nbsp;</p>
',
	'credit_writer' => 'The Telegraph, 26 July, 2022, https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'expired-pill-editorial-on-new-drugs-and-cosmetics-bill',
	'meta_title' => '',
	'meta_keywords' => '',
	'meta_description' => '',
	'noindex' => (int) 1,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => null,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {},
		(int) 7 => object(Cake\ORM\Entity) {},
		(int) 8 => object(Cake\ORM\Entity) {},
		(int) 9 => object(Cake\ORM\Entity) {},
		(int) 10 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 63323
$metaTitle = 'LATEST NEWS UPDATES | Expired pill: Editorial on new drugs and cosmetics bill'
$metaKeywords = 'good manufacturing practices,Drugs and Cosmetics Act, 1940,draft new drugs, medical devices and cosmetics bill,Intellectual Property Rights,IPR,IPRs,Public Health,pharmaceutical industry,open source vaccines,Generic medicines,Generic vaccines'
$metaDesc = '-The Telegraph

There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors

This month, the Union ministry of health published the...'
$disp = '<p style="text-align:justify">-The Telegraph</p><p style="text-align:justify"><em>There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors</em></p><p style="text-align:justify">This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with &lsquo;good manufacturing practices&rsquo; &mdash; a global standard when it comes to testing drugs &mdash; or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility &mdash; both of which can have huge implications for public health and profits of the pharmaceutical industry &mdash; leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, &lsquo;open source vaccines&rsquo; &mdash; generic versions of the vaccines already being used successfully &mdash; could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19.</p><p style="text-align:justify">Please <a href="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503" title="https://www.telegraphindia.com/opinion/expired-pill-editorial-on-new-drugs-and-cosmetics-bill/cid/1876503">click here</a> to read more.&nbsp;<br />&nbsp;</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Expired pill: Editorial on new drugs and cosmetics bill

-The Telegraph There is no mention of compliance with ‘good manufacturing practices’ or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the old law. Perhaps the gravest oversight in both the Act and the draft bill is a lax regulatory process. There is no mention of compliance with ‘good manufacturing practices’ — a global standard when it comes to testing drugs — or the need to make inspection reports public, leaving the process of regulation vague and dependent on the whims of drug inspectors. Lack of transparency on decisions such as approving a new drug or a manufacturing facility — both of which can have huge implications for public health and profits of the pharmaceutical industry — leaves the door open for irregularities like the falsification of data and test results. That is not all. The Covid-19 pandemic highlighted several infirmities in the pharmaceutical sector. The draft bill could have been a perfect opportunity to address these. For instance, ‘open source vaccines’ — generic versions of the vaccines already being used successfully — could have ensured that more people got access to the life-saving drugs. This would require waivers on intellectual property rights by pharmaceutical companies. Since the earliest stages of research and development often rely on substantial public sector investment, the government might have reserved the right to waive off IPR in an emergency. This lapse is even more surprising as India had recently proposed to the World Trade Organization to waive off IPR obligations to address shortages of products required for the prevention, control and treatment of Covid-19. Please click here to read more.